About Solara Active Pharma Sciences Ltd
Solara Active Pharma Sciences offers a diversified portfolio of high-value commercial APIs across more than 70 countries.
Founded
2017
CEO
RAJAGOPALAN RAMAKRISHNAN
Employees
3,108
HQ
Chennai, India
Finished Products
1Sale of Products
₹2,454.45Cr2Other Operating Revenues
₹50.53Cr3Scrap sales
₹26.52Cr4Sale of Services
₹25.40Cr5Export incentives
₹14.61Cr6Share of profit
₹1.17CrRaw Materials
1Cost of Material Consumed
₹1,342.31Cr2Purchase of Traded Goods
₹10.85CrAbout Solara Active Pharma Sciences Ltd
Solara Active Pharma Sciences offers a diversified portfolio of high-value commercial APIs across more than 70 countries.
Founded:2017
CEO:RAJAGOPALAN RAMAKRISHNAN
Employees:3,108
HQ:Chennai, India
Finished Products
1Sale of Products
₹2,454.45Cr2Other Operating Revenues
₹50.53Cr3Scrap sales
₹26.52Cr4Sale of Services
₹25.40Cr5Export incentives
₹14.61Cr6Share of profit
₹1.17CrRaw Materials
1Cost of Material Consumed
₹1,342.31Cr2Purchase of Traded Goods
₹10.85CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹712
52W Low
₹422
Volume350.17K
Avg VolumeN/A
Beta0.84
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-1887.21x
Valuation
P/B Ratio
2.44x
Valuation
EPS
₹-0.34
Valuation
Dividend Yield
0.00%
Valuation
ROE
-0.12%
Profitability
ROCE
4.81%
Profitability
Revenue by Segment
Contribution & growth by business line
Manufacture and sale of Active PharRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
2.8%
International
97.2%
Asia Pacific65.4%
Europe17.2%
South America6.6%
North America6.5%
India2.8%
Rest of the World1.5%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.55x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
2.0%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.